References
- Lemire JM. Immunomodulatory role of 1,25 dihydroxyvitamin D3. J Cell Biochem 1992;49:26–31.
- Mailer K, Oxholm P, Sorensen OH, Thymann M, Hoier-Madsen M, Bendtzen K. Abnormal vitamin D3 metabolism in patients with primary Sjogrens's syndrome. Ann Rheum Dis 1990;49: 682–4.
- Asmussen K, Andersen V, Bendixen G, Schiodt M, Oxholm P. A new model for classification of disease manifestations in primary Sjögren's syndrome: evaluation in a retrospective long-term study. J Int Med Res 1996;239:475–82.
- Manthorpe R, Oxholm P, Prause JU, Schiodt M. The Copen-hagen criteria for SjOgren's syndrome. Scand J Rheumatol Suppl 1986;61:19–21.
- Lund Bj, Lund Bi, Sorensen OH. Measurement of circulating 1,25-dihydroxyvitamin D in man. Changes in serum concentra-tions during treatment with 1 alfa-hydoxycholecalciferol. Acta Endocrinol 1979;91: 338–50.
- Lund Bj, Sorensen OH. Measurement of 25-hydroxyvitamin D in serum and its relation to sunshine, age and vitamin D intake in the Danish population. Scand J Clin Lab Invest 1979;39: 23–30.
- Asmussen K, Andersen V, Bendixen G, Prause JU, Thorn J, Wiik A, et al. Quantitative Assessment of Clinical Disease Sta-tus in Primary Sjögren's syndrome. Scand J Rheumatol 1997;26:197–205.
- Moutsopoulos HM. Sjogren's syndrome: autoimmune epitheli-tis. Clin Immunol Immunopathol 1994;72:162–5.
- Oxholm P, Asmussen K. Primary Sjögren's syndrome: the chal-lenge for classification of disease manifestations. J Int Med 1996;239:467–74.
- Mailer K, Kriegbaum NJ, Baslund B, Sorensen OH, Thymann M, Bendtzen K. Vitamin D3 metabolism in patients with rheu-matic diseases: Low serum level of 25-hydroxy vitamin D3 in patients with Systemic Lupus Erythematosus. Clin Rheumatol 1995;14:397–400.
- Als OS, Riis B, Christiansen C. Serum concentrations of vita-min D metabolites in rheumatoid arthritis. Clin Rheumatol 1987;6:238–43.
- Barbour GL, Coburn JW, Slatopolsky E, Norman AW, Horst RL. Hypercalcemia in an anephric patient with sarcoidosis: Evidence for extrarenal generation of 1,25 dihydroxyvitamin D3. N Engl J Med 1981;305: 440–3.
- Mawer EB, Hayes ME, Still PE, Davies M, Lumb GAL, Palit J, Holt PJL. Evidence for nonrenal synthesis of 1,25 Dihydroxy-vitamin D3in patients with inflammatory arthritis. J Bone Miner Res 1991;6: 733–38.
- Glijer B, Peterfy C, Tenenhouse A. The effect of vitamin D deficiency on secretion by rat parotid gland in vivo. J Physiol (London) 1985;363:323–34.
- Peterfy C, Tenenhouse A, Yu E. Vitamin D and parotid gland function in the rat. J Physiol (London) 1988;398:1–13.